Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation.

Autor: Sarmiento E; Transplant Immunology Group, Clinical Immunology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain., Arraya M, Jaramillo M, Diez P, Fernandez-Yañez J, Palomo J, Navarro J, Carbone J
Jazyk: angličtina
Zdroj: Clinical and experimental immunology [Clin Exp Immunol] 2014 Dec; Vol. 178 Suppl 1, pp. 156-8.
DOI: 10.1111/cei.12552
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje